Safety and efficacy of combined long-acting β-agonists and inhaled corticosteroids vs long-acting β-agonists monotherapy for stable COPD: a systematic review
GJ Rodrigo, JA Castro-Rodriguez, V Plaza - Chest, 2009 - Elsevier
Background Current guidelines recommend the use of inhaled corticosteroids (ICSs) added
to long-acting β 2-agonists (LABAs) for treatment of symptomatic patients with severe and …
to long-acting β 2-agonists (LABAs) for treatment of symptomatic patients with severe and …
Safety and efficacy of combined long-acting β-agonists and inhaled corticosteroids vs long-acting β-agonists monotherapy for stable COPD: A systematic review
GJ Rodrigo, JA Castro-Rodriguez, V Plaza - Chest, 2009 - portalrecerca.uab.cat
Background: Current guidelines recommend the use of inhaled corticosteroids (ICSs) added
to long-acting β2-agonists (LABAs) for treatment of symptomatic patients with severe and …
to long-acting β2-agonists (LABAs) for treatment of symptomatic patients with severe and …
Safety and Efficacy of Combined Long-Acting β-Agonists and Inhaled Corticosteroids vs Long-Acting β-Agonists Monotherapy for Stable COPD: A Systematic Review
GJ Rodrigo, JA Castro-Rodriguez, V Plaza - CHEST, 2009 - journal.chestnet.org
Background Current guidelines recommend the use of inhaled corticosteroids (ICSs) added
to long-acting β 2-agonists (LABAs) for treatment of symptomatic patients with severe and …
to long-acting β 2-agonists (LABAs) for treatment of symptomatic patients with severe and …
[PDF][PDF] Safety and Efficacy of Combined Long-Acting-Agonists and Inhaled Corticosteroids vs Long-Acting-Agonists Monotherapy for Stable COPD
GJ Rodrigo, JA Castro-Rodriguez, V Plaza - CHEST, 2009 - academia.edu
Background: Current guidelines recommend the use of inhaled corticosteroids (ICSs) added
to long-acting 2-agonists (LABAs) for treatment of symptomatic patients with severe and very …
to long-acting 2-agonists (LABAs) for treatment of symptomatic patients with severe and very …
Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review.
GJ Rodrigo, JA Castro-Rodriguez, V Plaza - Chest, 2009 - europepmc.org
Background Current guidelines recommend the use of inhaled corticosteroids (ICSs) added
to long-acting beta (2)-agonists (LABAs) for treatment of symptomatic patients with severe …
to long-acting beta (2)-agonists (LABAs) for treatment of symptomatic patients with severe …
[HTML][HTML] Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a …
GJ Rodrigo, JA Castro-Rodriguez… - Database of Abstracts of …, 2009 - ncbi.nlm.nih.gov
This review concluded that compared with long-acting beta-agonist (LABA) monotherapy,
the magnitude of benefits of combined LABA/inhaled corticosteroid therapy did not achieve …
the magnitude of benefits of combined LABA/inhaled corticosteroid therapy did not achieve …
[引用][C] Safety and Efficacy of Combined Long-Acting β-Agonists and Inhaled Corticosteroids vs Long-Acting β-Agonists Monotherapy for Stable COPD: A Systematic …
GJ RODRIGO… - … (American College of …, 2009 - pascal-francis.inist.fr
Safety and Efficacy of Combined Long-Acting β-Agonists and Inhaled Corticosteroids vs
Long-Acting β-Agonists Monotherapy for Stable COPD: A Systematic Review CNRS Inist …
Long-Acting β-Agonists Monotherapy for Stable COPD: A Systematic Review CNRS Inist …
Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review
GJ Rodrigo, JA Castro-Rodriguez, V Plaza - Chest, 2009 - pubmed.ncbi.nlm.nih.gov
Background Current guidelines recommend the use of inhaled corticosteroids (ICSs) added
to long-acting beta (2)-agonists (LABAs) for treatment of symptomatic patients with severe …
to long-acting beta (2)-agonists (LABAs) for treatment of symptomatic patients with severe …
[PDF][PDF] Safety and Efficacy of Combined Long-Acting-Agonists and Inhaled Corticosteroids vs Long-Acting-Agonists Monotherapy for Stable COPD
GJ Rodrigo, JA Castro-Rodriguez, V Plaza - CHEST, 2009 - academia.edu
Background: Current guidelines recommend the use of inhaled corticosteroids (ICSs) added
to long-acting 2-agonists (LABAs) for treatment of symptomatic patients with severe and very …
to long-acting 2-agonists (LABAs) for treatment of symptomatic patients with severe and very …